Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ACHR vs MRNA✓SelectedUSD · MRNAACHR vs MRNA performance historyLatest closeAs of-9.06%11/20
Stock and ETF performance explorer

ACHR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-53.4%
MRNA return
+153.9%
Excess return
-207.3%
Maximum drawdown
-78.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-9.1%-2.2%-6.9%-8.8%
7D-27.8%-12.7%-15.1%-26.8%
30D-24.8%-20.7%-4.1%-23.1%
3M-52.2%+46.3%-98.5%-54.0%
6M-49.7%+305.2%-354.9%-61.5%
YTD-61.3%+561.2%-622.5%-74.7%
1Y-57.6%+772.1%-829.7%-74.5%
3Y-53.4%+147.0%-200.3%-68.8%
All-53.4%+153.9%-207.3%-68.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling